New 172-page Whistleblower Complaint to SEBl Documents Sun Pharma’s Nexus with Aditya Medisales – I
The Securities and Exchange Board of India (SEBI) has received a new complaint, a few weeks ago, against Sun Pharma. This too has been filed by the same whistleblower who had filed a complaint in September last year, which was first reported by Moneylife.
Premium Content
This is a premium article. Your annual or monthly subscription will not give you access if it is outside your subscription period. You can buy it individually
Pay Per Article Gift An Article
Access will cover your subscription period. Archives not included. Articles outside the subscription period can be bought individually.
Yearly Digital Access Monthly Digital Access
Already a subscriber ? Log in
Free Helpline
Legal Credit